HIF1A and COVID-19: ECs in the lungs of COVID-19 patients exhibit an increase in both hypoxia-inducible factor 1-alpha (HIF-1α) and glucose transporter protein type 1 (GLUT1) expression, confirming local hypoxic stress as a potential trigger for this pathogenic process [4].